MedPath

Levemir FlexPen

Brand Name: Levemir FlexPen

Generic Name: Insulin detemir

Active
Registration Number

BR-1057

Dosage Form

Solution for Injection (SC)

Issuance Date

March 31, 2025

Expiry Date

March 18, 2031

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 U/mL
Packaging3 mL solution in cartridge (Type I glass) with a plunger (bromobutyl) and a stopper (bromobutyl/polyisoprene) contained in a pre-filled multidose disposable pen made of polypropylene (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antidiabetics
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Insulin detemirActive
Monograph: Insulin detemir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform